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tensive patients is a cost effective method of preventing stroke
and myocardial infarction (MI) among patients not taking
diuretics. METHODS: A decision analytic model was developed
to compare the costs of antihypertensive therapy, stroke, and MI
for patients screened for the a-adducin gene variant versus those
not screened (standard care). The outcomes possible for each
group were: no event, stroke, or MI. Epidemiological data for
the risk of stroke, MI and the effect of the a-adducin gene variant
were obtained from the literature. We assumed patients in the
standard care group continued on their current anti-hypertensive
regimen. In the screened patient group, we assumed 90% with
the a-adducin gene variant switched to a diuretic, whereas those
with the wild-type a-adducin gene continued their current
regimen. Cost data were obtained from the literature, and the
cost of the screening test was estimated based on currently avail-
able commercial tests for other gene variants. The analysis was
conducted in 2003 dollars from the payer perspective. One-way
sensitivity analyses were performed to test the robustness of the
results. RESULTS: The screening strategy saved $1427 and
increased Quality of Adjusted Life Years (QALY) by 0.10. When
the screening test was assumed to cost $2000, the incremental
cost increased to $6600/QALY. When only 10% of patients were
assumed to have switched to diuretics based on their screen 
result the incremental cost effectiveness ratio increased to
$56,317/QALY. CONCLUSIONS: The results of this cost effec-
tiveness analysis suggest that under most circumstances, screen-
ing patients on antihypertensive therapy for the a-adducin gene




CLAIM-BASED DRUG WASTAGE ESTIMATION: HOW HIDDEN
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OBJECTIVES: Dispensing large quantities of maintenance drugs
often causes concern of wastage due to patients changing med-
ication types. This study examines the prescription claims related
to patients changing medications, and establishes a new method
to estimate drug wastage and explores its implications on drug
dispensing policies. METHODS: The prescription claims of new
patients of three drug classes (satins, SSRIs and PPIs) in 2002
were extracted from Caremark’s prescription claim database.
Drug changes were identiﬁed and wasted days of supply were
calculated using the overlapped days between the new script ﬁll
date and the old script due date. The distributions of the wasted
days of the three drug classes in 90-day-supply reﬁlls at mail and
30-day-supply reﬁlls at retail were analyzed. Based on the ﬁnd-
ings, a separation process was developed to estimate average
wastage using clustering methods. RESULTS: The distributions
of the wasted days appeared to be bimodal. One component 
of the bimodal distributions was consistent with overlapping
pattern of non-changing drug reﬁlling patterns. The wastage
population identiﬁed two separate behavioral groups: reﬁll-
change people who change medications when their current med-
ications are due to reﬁll, and early-change people who change
medications even though they still have signiﬁcant amount of
existing medications. Reﬁll-change people were not likely to
waste medications. The new wastage rates were 0.4% in 90-
day supply and 0.2% in 30-day supply for statins, 0.2% in 90-
day supply and 0.5% 30-day supply for SSRIs and 1.2% in 
90-day supply and 0.9% in 30-day supply for PPIs. CONCLU-
SIONS: This study discovered a bimodal pattern in wastage. A
portion of the wastage implies hidden reﬁll pattern. Based on
these ﬁndings, this study establishes a new way to estimate pre-
scription drug wastage using claim data and shows that dis-
pensing large quantities does not necessarily lead to higher
wastage of medications.
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OBJECTIVES: The study objectives were to determine the preva-
lence and correlates of potentially inappropriate prescribing
among the ambulatory elderly using 2003 Beers criteria.
METHODS: Retrospective analysis was conducted of the 2001
public use ﬁles of the National Ambulatory Medical Care Survey
and the National Hospital Ambulatory Medical Care Survey. A
total of 7243 visits by individuals over 64 years old with at least
one prescription were analyzed. The 2003 Beers criteria were
used to deﬁne potentially inappropriate medications irrespective
of disease, dose, and duration. Multivariate logistic regression
using generalized estimating equations was performed to
examine associations between age, gender, race, payment source,
reason for visit, referral status, sharing of care by other phy-
sicians, number of medications, ambulatory setting type, 
metropolitan location of practice, and geographic region with
potentially inappropriate prescribing. Data was analyzed using
SAS 8.2 and SUDAAN 8.02. An alpha of 0.05 was required for
signiﬁcance. RESULTS: Potentially inappropriate medications
were prescribed in 17.8 million ofﬁce-based ambulatory visits
and 930,211 hospital-based ambulatory visits, 11.9% of all
ambulatory visits made by the elderly. The most common drug
classes were narcotic analgesics, antihistamines, and antiar-
rhythmic agents. Among all variables examined, location of
practice, referral status, and number of medications were asso-
ciated with receipt of a potentially inappropriate medication.
After adjusting for other risk factors, visits made in metropoli-
tan areas or by referred patients were more than twice as likely
to involve a potentially inappropriate medication. In addition,
compared with patients taking one medication, those taking two
(Odds Ratio (OR) = 2.64, 95% CI = 1.41–4.95), three (OR =
6.85, 95% CI = 3.15–14.88), or four or more medications (OR
= 7.43, 95% CI = 4.36–12.67) were more likely to receive a
potentially inappropriate medication. CONCLUSIONS: Poten-
tially inappropriate prescriptions were prevalent in nearly 12%
of ambulatory visits made by the elderly in 2001. More prospec-
tive efforts to improve prescribing practices and prevent drug-
related problems among the elderly are needed.
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OBJECTIVES: Retrospective Drug Utilization Review (RDUR)
can be effective in reducing drug-related problems and adverse
health outcomes. This study examined whether RDUR interven-
tion letters to prescribers impacted the recurrence of drug-
prescribing programs (exceptions) and evaluated the subsequent
effect on utilization of health care services. METHODS: Data
used were from combined pharmacy and medical claims from
January 2002 through November 2003. To assess the impact of
